

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | transcription from mitochondrial promoter (GO:0006390) | 7.46596526 |
| 2 | proline metabolic process (GO:0006560) | 7.22210961 |
| 3 | embryonic process involved in female pregnancy (GO:0060136) | 7.01972952 |
| 4 | replication fork processing (GO:0031297) | 6.68530151 |
| 5 | positive regulation of protein homooligomerization (GO:0032464) | 6.04131919 |
| 6 | establishment of apical/basal cell polarity (GO:0035089) | 6.02105873 |
| 7 | regulation of integrin activation (GO:0033623) | 6.00622268 |
| 8 | DNA deamination (GO:0045006) | 5.76923198 |
| 9 | oxidative demethylation (GO:0070989) | 5.56144236 |
| 10 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 5.53634426 |
| 11 | regulation of protein homooligomerization (GO:0032462) | 5.30345958 |
| 12 | mitochondrial DNA metabolic process (GO:0032042) | 5.21378803 |
| 13 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 5.11563131 |
| 14 | establishment of monopolar cell polarity (GO:0061162) | 5.11563131 |
| 15 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 4.86073710 |
| 16 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 4.86073710 |
| 17 | mitotic G1 DNA damage checkpoint (GO:0031571) | 4.72122139 |
| 18 | DNA strand renaturation (GO:0000733) | 4.69916252 |
| 19 | negative regulation of JAK-STAT cascade (GO:0046426) | 4.67185885 |
| 20 | histone H4-K12 acetylation (GO:0043983) | 4.66722120 |
| 21 | embryonic placenta development (GO:0001892) | 4.49834973 |
| 22 | regulation of translational fidelity (GO:0006450) | 4.42530957 |
| 23 | mRNA cleavage (GO:0006379) | 4.36384177 |
| 24 | negative regulation of cell cycle arrest (GO:0071157) | 4.35427817 |
| 25 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.30797513 |
| 26 | mitotic G1/S transition checkpoint (GO:0044819) | 4.26387393 |
| 27 | dosage compensation (GO:0007549) | 4.24267988 |
| 28 | cellular response to ATP (GO:0071318) | 4.13562334 |
| 29 | G1 DNA damage checkpoint (GO:0044783) | 4.03623681 |
| 30 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.02258137 |
| 31 | negative regulation of cell killing (GO:0031342) | 4.02258137 |
| 32 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97583051 |
| 33 | modulation by symbiont of host immune response (GO:0052553) | 3.97583051 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97583051 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 3.97583051 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97583051 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97583051 |
| 38 | negative regulation of Ras GTPase activity (GO:0034261) | 3.95483671 |
| 39 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.94605259 |
| 40 | convergent extension (GO:0060026) | 3.92960791 |
| 41 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.88726549 |
| 42 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.87077407 |
| 43 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.85883582 |
| 44 | response to peptidoglycan (GO:0032494) | 3.85834042 |
| 45 | trophectodermal cell differentiation (GO:0001829) | 3.85043027 |
| 46 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.83117493 |
| 47 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.83117493 |
| 48 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.83117493 |
| 49 | NIK/NF-kappaB signaling (GO:0038061) | 3.80881426 |
| 50 | protein retention in ER lumen (GO:0006621) | 3.78510701 |
| 51 | base-excision repair (GO:0006284) | 3.77155639 |
| 52 | negative regulation of protein oligomerization (GO:0032460) | 3.76650828 |
| 53 | GDP-mannose metabolic process (GO:0019673) | 3.75518551 |
| 54 | viral mRNA export from host cell nucleus (GO:0046784) | 3.75206427 |
| 55 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.68013249 |
| 56 | glandular epithelial cell development (GO:0002068) | 3.66263360 |
| 57 | activation of Rac GTPase activity (GO:0032863) | 3.66018306 |
| 58 | positive regulation by host of viral transcription (GO:0043923) | 3.64453226 |
| 59 | detection of bacterium (GO:0016045) | 3.63602320 |
| 60 | regulation of sister chromatid cohesion (GO:0007063) | 3.62849091 |
| 61 | formation of translation preinitiation complex (GO:0001731) | 3.61681534 |
| 62 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59322213 |
| 63 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59281014 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.56946435 |
| 65 | positive regulation of protein oligomerization (GO:0032461) | 3.56618309 |
| 66 | detection of other organism (GO:0098543) | 3.54417699 |
| 67 | apoptotic process involved in morphogenesis (GO:0060561) | 3.50197695 |
| 68 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.48138894 |
| 69 | negative regulation of mRNA processing (GO:0050686) | 3.42029414 |
| 70 | mannose metabolic process (GO:0006013) | 3.41810321 |
| 71 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.41341122 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 3.40729434 |
| 73 | regulation of protein oligomerization (GO:0032459) | 3.40543284 |
| 74 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.38892025 |
| 75 | cellular response to zinc ion (GO:0071294) | 3.36527430 |
| 76 | DNA integration (GO:0015074) | 3.36055573 |
| 77 | response to muramyl dipeptide (GO:0032495) | 3.36031755 |
| 78 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.35982620 |
| 79 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.34566490 |
| 80 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33568084 |
| 81 | anatomical structure regression (GO:0060033) | 3.32929795 |
| 82 | pre-miRNA processing (GO:0031054) | 3.32667617 |
| 83 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.32518036 |
| 84 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29612345 |
| 85 | macrophage activation involved in immune response (GO:0002281) | 3.25420556 |
| 86 | positive regulation of developmental pigmentation (GO:0048087) | 3.24813766 |
| 87 | nodal signaling pathway (GO:0038092) | 3.24600047 |
| 88 | leukocyte aggregation (GO:0070486) | 3.24015022 |
| 89 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23857378 |
| 90 | face development (GO:0060324) | 3.23444630 |
| 91 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 3.22604971 |
| 92 | regulation of podosome assembly (GO:0071801) | 3.22283191 |
| 93 | embryonic camera-type eye development (GO:0031076) | 3.20866212 |
| 94 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.18949970 |
| 95 | regulation of gene silencing by miRNA (GO:0060964) | 3.18949970 |
| 96 | regulation of gene silencing by RNA (GO:0060966) | 3.18949970 |
| 97 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.18834388 |
| 98 | germinal center formation (GO:0002467) | 3.18446664 |
| 99 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.16717149 |
| 100 | mitochondrial RNA metabolic process (GO:0000959) | 3.15763999 |
| 101 | positive regulation of receptor recycling (GO:0001921) | 3.15634649 |
| 102 | DNA demethylation (GO:0080111) | 3.14457057 |
| 103 | regulation of double-strand break repair (GO:2000779) | 3.13581426 |
| 104 | regulation of cell size (GO:0008361) | 3.11928250 |
| 105 | base-excision repair, AP site formation (GO:0006285) | 3.10139808 |
| 106 | labyrinthine layer development (GO:0060711) | 3.09753127 |
| 107 | non-recombinational repair (GO:0000726) | 3.09739916 |
| 108 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.09739916 |
| 109 | signal complex assembly (GO:0007172) | 3.08486972 |
| 110 | meiotic chromosome segregation (GO:0045132) | 3.07649996 |
| 111 | negative regulation of cell size (GO:0045792) | 3.07531858 |
| 112 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.07196125 |
| 113 | regulation of DNA damage checkpoint (GO:2000001) | 3.06711438 |
| 114 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.04533829 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 3.04416056 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 3.01597634 |
| 117 | termination of RNA polymerase II transcription (GO:0006369) | 3.01340097 |
| 118 | regulation of mast cell degranulation (GO:0043304) | 2.99846081 |
| 119 | negative regulation of RNA splicing (GO:0033119) | 2.98927141 |
| 120 | DNA double-strand break processing (GO:0000729) | 2.97984308 |
| 121 | regulation of hippo signaling (GO:0035330) | 2.97775860 |
| 122 | negative regulation of viral release from host cell (GO:1902187) | 2.97458649 |
| 123 | negative regulation of mRNA metabolic process (GO:1903312) | 2.97274571 |
| 124 | positive regulation of histone deacetylation (GO:0031065) | 2.97160568 |
| 125 | detection of external biotic stimulus (GO:0098581) | 2.95704009 |
| 126 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.95014099 |
| 127 | thymic T cell selection (GO:0045061) | 2.94162876 |
| 128 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92816808 |
| 129 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.92274115 |
| 130 | positive regulation of chromosome segregation (GO:0051984) | 2.91519607 |
| 131 | protein targeting to lysosome (GO:0006622) | 2.90611112 |
| 132 | establishment of protein localization to vacuole (GO:0072666) | 2.90611112 |
| 133 | protein targeting to vacuole (GO:0006623) | 2.90611112 |
| 134 | cellular zinc ion homeostasis (GO:0006882) | 2.90126785 |
| 135 | regulation of gamma-delta T cell activation (GO:0046643) | 2.89786119 |
| 136 | positive thymic T cell selection (GO:0045059) | 2.89612193 |
| 137 | response to type I interferon (GO:0034340) | 2.86956679 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.86787505 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.86787505 |
| 140 | regulation of early endosome to late endosome transport (GO:2000641) | 2.84766623 |
| 141 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.84515037 |
| 142 | glial cell migration (GO:0008347) | 2.84420413 |
| 143 | mitotic sister chromatid segregation (GO:0000070) | 2.83971610 |
| 144 | respiratory burst (GO:0045730) | 2.82564115 |
| 145 | maturation of 5.8S rRNA (GO:0000460) | 2.82437766 |
| 146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.79855574 |
| 147 | cellular response to virus (GO:0098586) | 2.77184542 |
| 148 | Golgi transport vesicle coating (GO:0048200) | 2.75501531 |
| 149 | COPI coating of Golgi vesicle (GO:0048205) | 2.75501531 |
| 150 | modulation by virus of host process (GO:0019054) | 2.72715463 |
| 151 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.69519481 |
| 152 | protein localization to endosome (GO:0036010) | 2.69274702 |
| 153 | modulation by symbiont of host cellular process (GO:0044068) | 2.68897502 |
| 154 | regulation of necroptotic process (GO:0060544) | 2.68178351 |
| 155 | response to host immune response (GO:0052572) | 2.67980018 |
| 156 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67980018 |
| 157 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.66809642 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.62888561 |
| 159 | negative regulation of type 2 immune response (GO:0002829) | 2.61653431 |
| 160 | negative regulation of interleukin-12 production (GO:0032695) | 2.61421398 |
| 161 | positive regulation of antigen processing and presentation (GO:0002579) | 2.61019346 |
| 162 | response to host (GO:0075136) | 2.60683300 |
| 163 | response to host defenses (GO:0052200) | 2.60683300 |
| 164 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.60683300 |
| 165 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59813509 |
| 166 | regulation of antigen processing and presentation (GO:0002577) | 2.59255200 |
| 167 | response to laminar fluid shear stress (GO:0034616) | 2.58615640 |
| 168 | positive regulation of protein deacetylation (GO:0090312) | 2.57316419 |
| 169 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.56755743 |
| 170 | negative regulation of innate immune response (GO:0045824) | 2.56327758 |
| 171 | detection of biotic stimulus (GO:0009595) | 2.56120830 |
| 172 | B cell receptor signaling pathway (GO:0050853) | 2.50983883 |
| 173 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.50564468 |
| 174 | regulation of defense response to virus by virus (GO:0050690) | 2.49569449 |
| 175 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.49567389 |
| 176 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.49567389 |
| 177 | glucose 6-phosphate metabolic process (GO:0051156) | 2.49410378 |
| 178 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.48690447 |
| 179 | negative regulation of phagocytosis (GO:0050765) | 2.48002351 |
| 180 | regulation of necrotic cell death (GO:0010939) | 2.47818242 |
| 181 | defense response to protozoan (GO:0042832) | 2.47472196 |
| 182 | regulation of regulated secretory pathway (GO:1903305) | 2.47367920 |
| 183 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.46012300 |
| 184 | T cell selection (GO:0045058) | 2.44570914 |
| 185 | granulocyte activation (GO:0036230) | 2.43829513 |
| 186 | regulation of type 2 immune response (GO:0002828) | 2.43825722 |
| 187 | detection of molecule of bacterial origin (GO:0032490) | 2.43662596 |
| 188 | response to protozoan (GO:0001562) | 2.42596056 |
| 189 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42306896 |
| 190 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.40738166 |
| 191 | neutrophil activation (GO:0042119) | 2.40518782 |
| 192 | negative regulation of necroptotic process (GO:0060546) | 2.38170079 |
| 193 | proline biosynthetic process (GO:0006561) | 10.0050922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.95755851 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.90484049 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.90484049 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.90484049 |
| 5 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.86271545 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.64075280 |
| 7 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.55608157 |
| 8 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.54910160 |
| 9 | * MYC_22102868_ChIP-Seq_BL_Human | 2.34264020 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.21116122 |
| 11 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.18417962 |
| 12 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.18094539 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.13314350 |
| 14 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.07633622 |
| 15 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.05794211 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.00849964 |
| 17 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.99190871 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.94931128 |
| 19 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.94189316 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.92477421 |
| 21 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.90861723 |
| 22 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.90535853 |
| 23 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.90315437 |
| 24 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.89255555 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.86633462 |
| 26 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.84158076 |
| 27 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.81854599 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80445009 |
| 29 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.78980011 |
| 30 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78949041 |
| 31 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.78824736 |
| 32 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.76950762 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.76025502 |
| 34 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.73135023 |
| 35 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.72794962 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69893608 |
| 37 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.67912850 |
| 38 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.66652037 |
| 39 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.64333384 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.62809355 |
| 41 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61978016 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.61168974 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.61154004 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.59401053 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.59095094 |
| 46 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.55975330 |
| 47 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.55628917 |
| 48 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54991283 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54736740 |
| 50 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53012265 |
| 51 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.52267197 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51762512 |
| 53 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51150678 |
| 54 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.50230794 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48613393 |
| 56 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.48101975 |
| 57 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.48045466 |
| 58 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47689271 |
| 59 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.47195374 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.46857916 |
| 61 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46642671 |
| 62 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46293743 |
| 63 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45228069 |
| 64 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45121645 |
| 65 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.44061693 |
| 66 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.43576880 |
| 67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43526742 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.43475992 |
| 69 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42263196 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.42160994 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38026477 |
| 72 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36276870 |
| 73 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.35943735 |
| 74 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35887295 |
| 75 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.35793157 |
| 76 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35522456 |
| 77 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.34367794 |
| 78 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.33769704 |
| 79 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32140457 |
| 80 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31106253 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.31010682 |
| 82 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30962327 |
| 83 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.30397408 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.29924313 |
| 85 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29647271 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28592260 |
| 87 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.27766122 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27739173 |
| 89 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25451175 |
| 90 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25130246 |
| 91 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.24863037 |
| 92 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24269498 |
| 93 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.23582090 |
| 94 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.23551165 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23229233 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.22486457 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.22164217 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21905420 |
| 99 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.21794824 |
| 100 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.21389224 |
| 101 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.21326429 |
| 102 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19375209 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19092818 |
| 104 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19069787 |
| 105 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17848389 |
| 106 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.17539988 |
| 107 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17127380 |
| 108 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.16339786 |
| 109 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.15359279 |
| 110 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14787146 |
| 111 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.14577919 |
| 112 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14065963 |
| 113 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.13745771 |
| 114 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.13549966 |
| 115 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.13143770 |
| 116 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.12973244 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12391802 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12253743 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12248222 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12053160 |
| 121 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.11581461 |
| 122 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11475901 |
| 123 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11423294 |
| 124 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10910526 |
| 125 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.10847938 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10693399 |
| 127 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.10069582 |
| 128 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10020373 |
| 129 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09936386 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09705288 |
| 131 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.09530516 |
| 132 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.08696875 |
| 133 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.08635561 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 1.08582275 |
| 135 | P68_20966046_ChIP-Seq_HELA_Human | 1.08538118 |
| 136 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.08459385 |
| 137 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08411036 |
| 138 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08182366 |
| 139 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08107937 |
| 140 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.07979247 |
| 141 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.07187871 |
| 142 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07162754 |
| 143 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.06983122 |
| 144 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06933319 |
| 145 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06914505 |
| 146 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06688171 |
| 147 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06676454 |
| 148 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.06471096 |
| 149 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 1.05903829 |
| 150 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05406182 |
| 151 | UTX_26944678_Chip-Seq_JUKART_Human | 1.05328205 |
| 152 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.03510350 |
| 153 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.00935277 |
| 154 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.00903830 |
| 155 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00743485 |
| 156 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00430566 |
| 157 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00237859 |
| 158 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.00086707 |
| 159 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.99235658 |
| 160 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98584739 |
| 161 | MAF_26560356_Chip-Seq_TH1_Human | 0.98032469 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008057_abnormal_DNA_replication | 5.52676053 |
| 2 | MP0009278_abnormal_bone_marrow | 4.34334297 |
| 3 | MP0003436_decreased_susceptibility_to | 3.80790232 |
| 4 | MP0003283_abnormal_digestive_organ | 3.76930163 |
| 5 | MP0005451_abnormal_body_composition | 3.64761606 |
| 6 | MP0003303_peritoneal_inflammation | 3.30277279 |
| 7 | MP0005171_absent_coat_pigmentation | 3.22666015 |
| 8 | MP0004233_abnormal_muscle_weight | 3.13853115 |
| 9 | MP0002653_abnormal_ependyma_morphology | 3.03380114 |
| 10 | MP0008260_abnormal_autophagy | 2.97132195 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.83391109 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.59539299 |
| 13 | MP0005076_abnormal_cell_differentiation | 2.45462933 |
| 14 | MP0001835_abnormal_antigen_presentation | 2.37968726 |
| 15 | MP0010352_gastrointestinal_tract_polyps | 2.36436427 |
| 16 | MP0002009_preneoplasia | 2.35810256 |
| 17 | MP0003724_increased_susceptibility_to | 2.30376163 |
| 18 | MP0009840_abnormal_foam_cell | 2.28721960 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.26915527 |
| 20 | MP0005025_abnormal_response_to | 2.24554325 |
| 21 | MP0005397_hematopoietic_system_phenotyp | 2.19756802 |
| 22 | MP0001545_abnormal_hematopoietic_system | 2.19756802 |
| 23 | MP0001790_abnormal_immune_system | 2.17674932 |
| 24 | MP0005387_immune_system_phenotype | 2.17674932 |
| 25 | MP0002877_abnormal_melanocyte_morpholog | 2.16312149 |
| 26 | MP0008995_early_reproductive_senescence | 2.13259463 |
| 27 | MP0002419_abnormal_innate_immunity | 2.11707522 |
| 28 | MP0010094_abnormal_chromosome_stability | 2.11369021 |
| 29 | MP0003119_abnormal_digestive_system | 2.11276378 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 2.10790519 |
| 31 | MP0004947_skin_inflammation | 2.10576892 |
| 32 | MP0005000_abnormal_immune_tolerance | 2.07988338 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 2.06975271 |
| 34 | MP0008877_abnormal_DNA_methylation | 2.01467789 |
| 35 | MP0004957_abnormal_blastocyst_morpholog | 2.00635323 |
| 36 | MP0001800_abnormal_humoral_immune | 1.99771125 |
| 37 | MP0003300_gastrointestinal_ulcer | 1.91023255 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.90938838 |
| 39 | MP0009785_altered_susceptibility_to | 1.89055461 |
| 40 | MP0002723_abnormal_immune_serum | 1.84049423 |
| 41 | MP0004133_heterotaxia | 1.79426834 |
| 42 | MP0001819_abnormal_immune_cell | 1.77074632 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.76840054 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.75826486 |
| 45 | MP0005671_abnormal_response_to | 1.74623096 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.71675776 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.71130586 |
| 48 | MP0002084_abnormal_developmental_patter | 1.69778076 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.67336275 |
| 50 | MP0003786_premature_aging | 1.64767394 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.62420706 |
| 52 | MP0001533_abnormal_skeleton_physiology | 1.61401859 |
| 53 | MP0003453_abnormal_keratinocyte_physiol | 1.61222645 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.61116284 |
| 55 | MP0008058_abnormal_DNA_repair | 1.59788815 |
| 56 | MP0004510_myositis | 1.59636430 |
| 57 | MP0003183_abnormal_peptide_metabolism | 1.59144631 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.58312246 |
| 59 | MP0004858_abnormal_nervous_system | 1.56731814 |
| 60 | MP0001697_abnormal_embryo_size | 1.55633325 |
| 61 | MP0002398_abnormal_bone_marrow | 1.55280481 |
| 62 | MP0000858_altered_metastatic_potential | 1.52421223 |
| 63 | MP0002085_abnormal_embryonic_tissue | 1.51605630 |
| 64 | MP0000462_abnormal_digestive_system | 1.47913915 |
| 65 | MP0003693_abnormal_embryo_hatching | 1.45011393 |
| 66 | MP0000716_abnormal_immune_system | 1.44948902 |
| 67 | MP0004197_abnormal_fetal_growth/weight/ | 1.44641759 |
| 68 | MP0000490_abnormal_crypts_of | 1.44623359 |
| 69 | MP0001293_anophthalmia | 1.44535295 |
| 70 | MP0000371_diluted_coat_color | 1.44241241 |
| 71 | MP0004381_abnormal_hair_follicle | 1.43882915 |
| 72 | MP0005174_abnormal_tail_pigmentation | 1.40905121 |
| 73 | MP0001672_abnormal_embryogenesis/_devel | 1.37500097 |
| 74 | MP0005380_embryogenesis_phenotype | 1.37500097 |
| 75 | MP0002269_muscular_atrophy | 1.33706827 |
| 76 | MP0001873_stomach_inflammation | 1.33438491 |
| 77 | MP0002722_abnormal_immune_system | 1.30899419 |
| 78 | MP0003077_abnormal_cell_cycle | 1.30059549 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.29032602 |
| 80 | MP0002396_abnormal_hematopoietic_system | 1.28695222 |
| 81 | MP0002132_abnormal_respiratory_system | 1.28632206 |
| 82 | MP0002429_abnormal_blood_cell | 1.28369717 |
| 83 | MP0000678_abnormal_parathyroid_gland | 1.27722182 |
| 84 | MP0000350_abnormal_cell_proliferation | 1.23044922 |
| 85 | MP0002249_abnormal_larynx_morphology | 1.23039362 |
| 86 | MP0000470_abnormal_stomach_morphology | 1.22413172 |
| 87 | MP0000689_abnormal_spleen_morphology | 1.20539827 |
| 88 | MP0001730_embryonic_growth_arrest | 1.18488439 |
| 89 | MP0003045_fibrosis | 1.18069786 |
| 90 | MP0000579_abnormal_nail_morphology | 1.16279885 |
| 91 | MP0000639_abnormal_adrenal_gland | 1.16169630 |
| 92 | MP0010307_abnormal_tumor_latency | 1.14416000 |
| 93 | MP0008469_abnormal_protein_level | 1.12557366 |
| 94 | MP0003984_embryonic_growth_retardation | 1.11735129 |
| 95 | MP0005360_urolithiasis | 1.10705678 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.09317920 |
| 97 | MP0002796_impaired_skin_barrier | 1.09008612 |
| 98 | MP0008932_abnormal_embryonic_tissue | 1.08332214 |
| 99 | MP0002080_prenatal_lethality | 1.07910794 |
| 100 | MP0002088_abnormal_embryonic_growth/wei | 1.07263522 |
| 101 | MP0005501_abnormal_skin_physiology | 1.02367447 |
| 102 | MP0002019_abnormal_tumor_incidence | 1.02260706 |
| 103 | MP0000685_abnormal_immune_system | 1.01126849 |
| 104 | MP0001348_abnormal_lacrimal_gland | 1.00741220 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.99335044 |
| 106 | MP0003091_abnormal_cell_migration | 0.99256680 |
| 107 | MP0005409_darkened_coat_color | 0.98674403 |
| 108 | MP0003075_altered_response_to | 0.98291019 |
| 109 | MP0002111_abnormal_tail_morphology | 0.97645334 |
| 110 | MP0002282_abnormal_trachea_morphology | 0.96933010 |
| 111 | MP0005075_abnormal_melanosome_morpholog | 0.95928068 |
| 112 | MP0005083_abnormal_biliary_tract | 0.91521468 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.90390257 |
| 114 | MP0005220_abnormal_exocrine_pancreas | 0.89993824 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.89836384 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.89606769 |
| 117 | MP0002693_abnormal_pancreas_physiology | 0.89447589 |
| 118 | MP0005375_adipose_tissue_phenotype | 0.88992100 |
| 119 | MP0002075_abnormal_coat/hair_pigmentati | 0.88893875 |
| 120 | MP0003935_abnormal_craniofacial_develop | 0.88637680 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.86634760 |
| 122 | MP0002932_abnormal_joint_morphology | 0.86628368 |
| 123 | MP0005390_skeleton_phenotype | 0.86170036 |
| 124 | MP0003705_abnormal_hypodermis_morpholog | 0.85843598 |
| 125 | MP0001851_eye_inflammation | 0.85401209 |
| 126 | MP0002933_joint_inflammation | 0.85348378 |
| 127 | MP0005670_abnormal_white_adipose | 0.83890796 |
| 128 | MP0000313_abnormal_cell_death | 0.83863263 |
| 129 | MP0002405_respiratory_system_inflammati | 0.83329566 |
| 130 | MP0002970_abnormal_white_adipose | 0.83146486 |
| 131 | MP0005310_abnormal_salivary_gland | 0.83110799 |
| 132 | MP0002138_abnormal_hepatobiliary_system | 0.82271773 |
| 133 | MP0003566_abnormal_cell_adhesion | 0.81779573 |
| 134 | MP0009931_abnormal_skin_appearance | 0.81344970 |
| 135 | MP0008961_abnormal_basal_metabolism | 0.79674210 |
| 136 | MP0003828_pulmonary_edema | 0.78896956 |
| 137 | MP0009764_decreased_sensitivity_to | 0.78836684 |
| 138 | MP0001340_abnormal_eyelid_morphology | 0.77688245 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.77244858 |
| 140 | MP0006082_CNS_inflammation | 0.76535320 |
| 141 | MP0001186_pigmentation_phenotype | 0.75781513 |
| 142 | MP0002116_abnormal_craniofacial_bone | 0.75769097 |
| 143 | MP0005253_abnormal_eye_physiology | 0.75499255 |
| 144 | MP0010234_abnormal_vibrissa_follicle | 0.75369849 |
| 145 | MP0000015_abnormal_ear_pigmentation | 0.74564714 |
| 146 | MP0009333_abnormal_splenocyte_physiolog | 0.74398266 |
| 147 | MP0005166_decreased_susceptibility_to | 0.73688321 |
| 148 | MP0001145_abnormal_male_reproductive | 0.73446789 |
| 149 | MP0001324_abnormal_eye_pigmentation | 0.73210650 |
| 150 | MP0002114_abnormal_axial_skeleton | 0.72982477 |
| 151 | MP0005621_abnormal_cell_physiology | 0.72850504 |
| 152 | MP0003329_amyloid_beta_deposits | 0.72817922 |
| 153 | MP0000516_abnormal_urinary_system | 0.72465630 |
| 154 | MP0005367_renal/urinary_system_phenotyp | 0.72465630 |
| 155 | MP0001849_ear_inflammation | 0.72228462 |
| 156 | MP0008874_decreased_physiological_sensi | 0.72212174 |
| 157 | MP0001853_heart_inflammation | 0.72035698 |
| 158 | MP0009115_abnormal_fat_cell | 0.71951438 |
| 159 | MP0003567_abnormal_fetal_cardiomyocyte | 0.71800962 |
| 160 | MP0002089_abnormal_postnatal_growth/wei | 0.71528723 |
| 161 | MP0000609_abnormal_liver_physiology | 0.71291693 |
| 162 | MP0005266_abnormal_metabolism | 0.70951722 |
| 163 | MP0002166_altered_tumor_susceptibility | 0.70682179 |
| 164 | MP0003763_abnormal_thymus_physiology | 0.69822058 |
| 165 | MP0000477_abnormal_intestine_morphology | 0.69706367 |
| 166 | MP0003279_aneurysm | 0.69497473 |
| 167 | MP0003755_abnormal_palate_morphology | 0.67793507 |
| 168 | MP0003866_abnormal_defecation | 0.66137461 |
| 169 | MP0000432_abnormal_head_morphology | 0.63341827 |
| 170 | MP0005391_vision/eye_phenotype | 0.63249860 |
| 171 | MP0004185_abnormal_adipocyte_glucose | 0.63135229 |
| 172 | MP0001929_abnormal_gametogenesis | 0.63069532 |
| 173 | MP0000703_abnormal_thymus_morphology | 0.62794511 |
| 174 | MP0005023_abnormal_wound_healing | 0.60421556 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Rib fusion (HP:0000902) | 5.48525852 |
| 2 | Pustule (HP:0200039) | 4.52816858 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.38178642 |
| 4 | Facial hemangioma (HP:0000329) | 4.37291045 |
| 5 | Rectal fistula (HP:0100590) | 4.23559204 |
| 6 | Rectovaginal fistula (HP:0000143) | 4.23559204 |
| 7 | Male infertility (HP:0003251) | 4.21995593 |
| 8 | Turricephaly (HP:0000262) | 4.21229296 |
| 9 | Intestinal fistula (HP:0100819) | 4.18927796 |
| 10 | Annular pancreas (HP:0001734) | 4.17754626 |
| 11 | Poikiloderma (HP:0001029) | 3.95978180 |
| 12 | Ulnar bowing (HP:0003031) | 3.91622045 |
| 13 | Increased IgM level (HP:0003496) | 3.90047300 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.84707937 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.84707937 |
| 16 | Concave nail (HP:0001598) | 3.84699403 |
| 17 | Vaginal fistula (HP:0004320) | 3.83159404 |
| 18 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.82955292 |
| 19 | Large for gestational age (HP:0001520) | 3.81482211 |
| 20 | Tongue fasciculations (HP:0001308) | 3.73073095 |
| 21 | Short humerus (HP:0005792) | 3.64200445 |
| 22 | Intestinal atresia (HP:0011100) | 3.61763173 |
| 23 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.55746366 |
| 24 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.55746366 |
| 25 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.55746366 |
| 26 | Hypochromic microcytic anemia (HP:0004840) | 3.54708004 |
| 27 | Alopecia of scalp (HP:0002293) | 3.50232024 |
| 28 | Orthostatic hypotension (HP:0001278) | 3.48872903 |
| 29 | Abnormality of macrophages (HP:0004311) | 3.46623271 |
| 30 | Dysostosis multiplex (HP:0000943) | 3.46174351 |
| 31 | Aplasia/hypoplasia of the humerus (HP:0006507) | 3.43912318 |
| 32 | Muscle fibrillation (HP:0010546) | 3.42951229 |
| 33 | Recurrent abscess formation (HP:0002722) | 3.40100637 |
| 34 | Cellulitis (HP:0100658) | 3.39985787 |
| 35 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 3.38148830 |
| 36 | Recurrent bacterial skin infections (HP:0005406) | 3.33568515 |
| 37 | Broad face (HP:0000283) | 3.31962979 |
| 38 | Vertebral hypoplasia (HP:0008417) | 3.30274201 |
| 39 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 3.30274201 |
| 40 | Anteriorly placed anus (HP:0001545) | 3.25460535 |
| 41 | Dysautonomia (HP:0002459) | 3.11791070 |
| 42 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.04570521 |
| 43 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.04570521 |
| 44 | Increased IgE level (HP:0003212) | 2.98956174 |
| 45 | Myositis (HP:0100614) | 2.98430301 |
| 46 | Obstructive sleep apnea (HP:0002870) | 2.93563278 |
| 47 | Volvulus (HP:0002580) | 2.88375918 |
| 48 | Hemorrhage of the eye (HP:0011885) | 2.86098710 |
| 49 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83396511 |
| 50 | Obstructive lung disease (HP:0006536) | 2.83396511 |
| 51 | Mediastinal lymphadenopathy (HP:0100721) | 2.83202992 |
| 52 | Congenital hip dislocation (HP:0001374) | 2.81960772 |
| 53 | Cerebral aneurysm (HP:0004944) | 2.79465090 |
| 54 | Meningitis (HP:0001287) | 2.79228675 |
| 55 | Coronal craniosynostosis (HP:0004440) | 2.73909046 |
| 56 | Basal cell carcinoma (HP:0002671) | 2.73408002 |
| 57 | Abnormality of male internal genitalia (HP:0000022) | 2.71547502 |
| 58 | Cervical subluxation (HP:0003308) | 2.69410411 |
| 59 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.67420823 |
| 60 | Orchitis (HP:0100796) | 2.65491114 |
| 61 | Growth hormone excess (HP:0000845) | 2.60744968 |
| 62 | Albinism (HP:0001022) | 2.60386642 |
| 63 | Absent radius (HP:0003974) | 2.60208299 |
| 64 | Gastrointestinal inflammation (HP:0004386) | 2.60131944 |
| 65 | Astrocytoma (HP:0009592) | 2.58070217 |
| 66 | Abnormality of the astrocytes (HP:0100707) | 2.58070217 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.56843892 |
| 68 | Colitis (HP:0002583) | 2.56779194 |
| 69 | Squamous cell carcinoma (HP:0002860) | 2.56476479 |
| 70 | J-shaped sella turcica (HP:0002680) | 2.53019699 |
| 71 | Alacrima (HP:0000522) | 2.50790440 |
| 72 | Increased connective tissue (HP:0009025) | 2.50736780 |
| 73 | Abnormal hemoglobin (HP:0011902) | 2.50495444 |
| 74 | Spinal muscular atrophy (HP:0007269) | 2.48923919 |
| 75 | Gingivitis (HP:0000230) | 2.47369752 |
| 76 | Polycythemia (HP:0001901) | 2.47135000 |
| 77 | Vertebral fusion (HP:0002948) | 2.46755030 |
| 78 | Recurrent fungal infections (HP:0002841) | 2.46411906 |
| 79 | Joint stiffness (HP:0001387) | 2.46129935 |
| 80 | Broad alveolar ridges (HP:0000187) | 2.44124588 |
| 81 | Aplasia involving forearm bones (HP:0009822) | 2.42013399 |
| 82 | Absent forearm bone (HP:0003953) | 2.42013399 |
| 83 | Abnormality of the aortic arch (HP:0012303) | 2.40316263 |
| 84 | Hamartoma (HP:0010566) | 2.40078096 |
| 85 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.39398576 |
| 86 | Agammaglobulinemia (HP:0004432) | 2.39150208 |
| 87 | Patellar aplasia (HP:0006443) | 2.37396194 |
| 88 | Hypotelorism (HP:0000601) | 2.37386611 |
| 89 | Absent thumb (HP:0009777) | 2.36714747 |
| 90 | Hyperacusis (HP:0010780) | 2.35337340 |
| 91 | Increased cerebral lipofuscin (HP:0011813) | 2.34106353 |
| 92 | Short chin (HP:0000331) | 2.31519255 |
| 93 | Ependymoma (HP:0002888) | 2.30347423 |
| 94 | Loss of speech (HP:0002371) | 2.28869357 |
| 95 | Inflammation of the large intestine (HP:0002037) | 2.27060968 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.26993426 |
| 97 | Cholecystitis (HP:0001082) | 2.26993426 |
| 98 | Increased serum ferritin (HP:0003281) | 2.25684607 |
| 99 | Premature skin wrinkling (HP:0100678) | 2.25307733 |
| 100 | Abnormality of the lower motor neuron (HP:0002366) | 2.24100427 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 2.22934231 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.22917467 |
| 103 | Bowing of the arm (HP:0006488) | 2.22568246 |
| 104 | Bowed forearm bones (HP:0003956) | 2.22568246 |
| 105 | Hypercortisolism (HP:0001578) | 2.20362015 |
| 106 | Reticulocytosis (HP:0001923) | 2.16133844 |
| 107 | Metaphyseal cupping (HP:0003021) | 2.16131244 |
| 108 | Stridor (HP:0010307) | 2.15918542 |
| 109 | Thin bony cortex (HP:0002753) | 2.15918025 |
| 110 | Purpura (HP:0000979) | 2.15347308 |
| 111 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.14820826 |
| 112 | Neoplasm of the oral cavity (HP:0100649) | 2.13624932 |
| 113 | Distal lower limb amyotrophy (HP:0008944) | 2.13585975 |
| 114 | Abnormality of glycolipid metabolism (HP:0010969) | 2.13344202 |
| 115 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.13344202 |
| 116 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.13344202 |
| 117 | Easy fatigability (HP:0003388) | 2.12890148 |
| 118 | Hypertensive crisis (HP:0100735) | 2.12771842 |
| 119 | Retrobulbar optic neuritis (HP:0100654) | 2.12291180 |
| 120 | Optic neuritis (HP:0100653) | 2.12291180 |
| 121 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.11782960 |
| 122 | Prolonged bleeding time (HP:0003010) | 2.10939281 |
| 123 | Recurrent viral infections (HP:0004429) | 2.10399754 |
| 124 | Hypochromic anemia (HP:0001931) | 2.10005772 |
| 125 | Selective tooth agenesis (HP:0001592) | 2.08927649 |
| 126 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.08781516 |
| 127 | Diaphragmatic weakness (HP:0009113) | 2.06946786 |
| 128 | Premature graying of hair (HP:0002216) | 2.06630536 |
| 129 | Gastrointestinal stroma tumor (HP:0100723) | 2.06439919 |
| 130 | Recurrent skin infections (HP:0001581) | 2.06257851 |
| 131 | Petechiae (HP:0000967) | 2.06232089 |
| 132 | Hypertriglyceridemia (HP:0002155) | 2.05841740 |
| 133 | Polygenic inheritance (HP:0010982) | 2.05632393 |
| 134 | Urticaria (HP:0001025) | 2.05265887 |
| 135 | Clumsiness (HP:0002312) | 2.04959480 |
| 136 | Short 5th finger (HP:0009237) | 2.04729340 |
| 137 | IgA deficiency (HP:0002720) | 2.04377886 |
| 138 | Split hand (HP:0001171) | 2.04284557 |
| 139 | Hepatosplenomegaly (HP:0001433) | 2.04030728 |
| 140 | Vasculitis (HP:0002633) | 2.01391834 |
| 141 | Choanal stenosis (HP:0000452) | 1.99564112 |
| 142 | Emphysema (HP:0002097) | 1.99491680 |
| 143 | Acute lymphatic leukemia (HP:0006721) | 1.98399116 |
| 144 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.97295805 |
| 145 | Gastrointestinal atresia (HP:0002589) | 1.97125768 |
| 146 | Osteomyelitis (HP:0002754) | 1.96740282 |
| 147 | Disproportionate tall stature (HP:0001519) | 1.96576437 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.96231639 |
| 149 | Distal upper limb amyotrophy (HP:0007149) | 1.94087993 |
| 150 | Upper limb amyotrophy (HP:0009129) | 1.94087993 |
| 151 | Decreased lacrimation (HP:0000633) | 1.92725178 |
| 152 | Capillary hemangiomas (HP:0005306) | 1.91594765 |
| 153 | Hypotrichosis (HP:0001006) | 1.90332509 |
| 154 | Abnormality of the fingertips (HP:0001211) | 1.89945600 |
| 155 | Epistaxis (HP:0000421) | 1.88783302 |
| 156 | Flat acetabular roof (HP:0003180) | 1.87635537 |
| 157 | Distal lower limb muscle weakness (HP:0009053) | 1.87467701 |
| 158 | Sepsis (HP:0100806) | 1.87446960 |
| 159 | Achilles tendon contracture (HP:0001771) | 1.85633603 |
| 160 | Glioma (HP:0009733) | 1.85421280 |
| 161 | Thoracic kyphosis (HP:0002942) | 1.84538578 |
| 162 | Cheilitis (HP:0100825) | 1.84248266 |
| 163 | Chest pain (HP:0100749) | 1.83846914 |
| 164 | Abnormality of the labia minora (HP:0012880) | 1.83154796 |
| 165 | Myopathic facies (HP:0002058) | 1.82334985 |
| 166 | Abnormality of the thoracic spine (HP:0100711) | 1.81771827 |
| 167 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.81742085 |
| 168 | Bifid uvula (HP:0000193) | 1.81705244 |
| 169 | Long palpebral fissure (HP:0000637) | 1.81699644 |
| 170 | Malnutrition (HP:0004395) | 1.80734523 |
| 171 | Encephalitis (HP:0002383) | 1.80054601 |
| 172 | Papilloma (HP:0012740) | 1.79738263 |
| 173 | Verrucae (HP:0200043) | 1.79738263 |
| 174 | Ragged-red muscle fibers (HP:0003200) | 1.79505908 |
| 175 | Generalized amyotrophy (HP:0003700) | 1.79459866 |
| 176 | Tented upper lip vermilion (HP:0010804) | 1.78014338 |
| 177 | Amelogenesis imperfecta (HP:0000705) | 1.77668961 |
| 178 | Shawl scrotum (HP:0000049) | 1.77625383 |
| 179 | Broad thumb (HP:0011304) | 1.77621578 |
| 180 | Lower limb hyperreflexia (HP:0002395) | 1.77612973 |
| 181 | Popliteal pterygium (HP:0009756) | 1.77093006 |
| 182 | Slow saccadic eye movements (HP:0000514) | 1.76568891 |
| 183 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.74648483 |
| 184 | Bulbar palsy (HP:0001283) | 1.74510494 |
| 185 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74031561 |
| 186 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.74005797 |
| 187 | Amyloidosis (HP:0011034) | 1.73195412 |
| 188 | Abnormality of iron homeostasis (HP:0011031) | 1.73045357 |
| 189 | Gastrointestinal dysmotility (HP:0002579) | 1.72959282 |
| 190 | Deep venous thrombosis (HP:0002625) | 1.71553274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ICK | 6.02904105 |
| 2 | MAPK15 | 5.34701212 |
| 3 | DDR2 | 4.23054730 |
| 4 | MAP3K6 | 3.91201385 |
| 5 | TYRO3 | 3.00484913 |
| 6 | SMG1 | 2.91989032 |
| 7 | MAP3K11 | 2.90680670 |
| 8 | MATK | 2.63807506 |
| 9 | PINK1 | 2.49230771 |
| 10 | TESK2 | 2.46868209 |
| 11 | IRAK3 | 2.36455662 |
| 12 | PRKD2 | 2.33609552 |
| 13 | CDK12 | 2.32884469 |
| 14 | FGR | 2.29978091 |
| 15 | PDGFRA | 2.29064697 |
| 16 | CSK | 2.12661740 |
| 17 | DYRK1B | 2.12524489 |
| 18 | DAPK1 | 2.11033283 |
| 19 | IRAK4 | 2.05109349 |
| 20 | BMX | 2.04483879 |
| 21 | RIPK4 | 2.04189760 |
| 22 | UHMK1 | 2.03205119 |
| 23 | MAP2K3 | 1.89715832 |
| 24 | CDK7 | 1.72355748 |
| 25 | MAP3K10 | 1.66840121 |
| 26 | YES1 | 1.62974890 |
| 27 | EPHB1 | 1.58735913 |
| 28 | PIM2 | 1.57362674 |
| 29 | TESK1 | 1.56019343 |
| 30 | TBK1 | 1.54192397 |
| 31 | TYK2 | 1.49192651 |
| 32 | TNK2 | 1.47858651 |
| 33 | HIPK2 | 1.42234653 |
| 34 | NME2 | 1.42210660 |
| 35 | AKT3 | 1.41836346 |
| 36 | SIK3 | 1.39479459 |
| 37 | CDC42BPA | 1.37945615 |
| 38 | PKN2 | 1.36257109 |
| 39 | MAP3K3 | 1.31911749 |
| 40 | ERN1 | 1.31606143 |
| 41 | TRIB3 | 1.25407311 |
| 42 | PIM1 | 1.24807226 |
| 43 | ZAP70 | 1.20236055 |
| 44 | CDK6 | 1.20194684 |
| 45 | MAP3K1 | 1.19552232 |
| 46 | FGFR4 | 1.18657326 |
| 47 | MAPK11 | 1.17425673 |
| 48 | TRPM7 | 1.16762640 |
| 49 | MAP3K13 | 1.10374877 |
| 50 | BLK | 1.09523783 |
| 51 | RPS6KL1 | 1.07884605 |
| 52 | RPS6KC1 | 1.07884605 |
| 53 | PTK6 | 1.07523409 |
| 54 | LATS2 | 1.06833677 |
| 55 | MAP3K14 | 1.06716473 |
| 56 | CHEK2 | 1.06708786 |
| 57 | MTOR | 1.05848577 |
| 58 | KSR2 | 1.01911765 |
| 59 | JAK3 | 1.00133975 |
| 60 | GSK3A | 0.98289892 |
| 61 | KDR | 0.96824285 |
| 62 | TTN | 0.94020024 |
| 63 | BTK | 0.92696265 |
| 64 | RPS6KA6 | 0.92653569 |
| 65 | PRKD3 | 0.90719222 |
| 66 | PASK | 0.89752118 |
| 67 | ARAF | 0.88311319 |
| 68 | IRAK2 | 0.88296197 |
| 69 | IKBKE | 0.85899023 |
| 70 | RPS6KA2 | 0.85558935 |
| 71 | NEK2 | 0.82255299 |
| 72 | PRKAA1 | 0.80776591 |
| 73 | PLK1 | 0.79642280 |
| 74 | DYRK3 | 0.79032962 |
| 75 | FES | 0.78804372 |
| 76 | PDPK1 | 0.76398173 |
| 77 | HCK | 0.75775518 |
| 78 | EPHA2 | 0.74138262 |
| 79 | MAP2K2 | 0.73249188 |
| 80 | PRPF4B | 0.72878576 |
| 81 | CSF1R | 0.72562232 |
| 82 | IKBKB | 0.72390882 |
| 83 | INSRR | 0.69235067 |
| 84 | TAOK1 | 0.68985512 |
| 85 | PTK2 | 0.67119299 |
| 86 | FLT3 | 0.66802633 |
| 87 | MST1R | 0.65520376 |
| 88 | RPS6KA1 | 0.64066906 |
| 89 | TAOK2 | 0.62470809 |
| 90 | MAP3K8 | 0.62211114 |
| 91 | RIPK1 | 0.58750545 |
| 92 | ATR | 0.57378308 |
| 93 | MAP3K7 | 0.57228011 |
| 94 | CDK2 | 0.54590723 |
| 95 | ALK | 0.54328823 |
| 96 | PDK1 | 0.53809199 |
| 97 | BRAF | 0.53248925 |
| 98 | MAPK12 | 0.52699933 |
| 99 | LRRK2 | 0.52231927 |
| 100 | MUSK | 0.51475360 |
| 101 | MAP4K1 | 0.51264649 |
| 102 | STK10 | 0.51034163 |
| 103 | RPS6KB2 | 0.50785288 |
| 104 | LCK | 0.49333242 |
| 105 | PHKG2 | 0.49246315 |
| 106 | PHKG1 | 0.49246315 |
| 107 | SYK | 0.49105879 |
| 108 | MARK2 | 0.48925781 |
| 109 | MAPK7 | 0.48106294 |
| 110 | SIK1 | 0.46187394 |
| 111 | PDGFRB | 0.45701776 |
| 112 | KIT | 0.45664720 |
| 113 | MARK3 | 0.43332027 |
| 114 | JAK1 | 0.42607970 |
| 115 | MAPK1 | 0.42216761 |
| 116 | CHEK1 | 0.42123204 |
| 117 | MAPK4 | 0.40961974 |
| 118 | EGFR | 0.40942096 |
| 119 | PRKG2 | 0.40811917 |
| 120 | BRD4 | 0.39744790 |
| 121 | MAPK14 | 0.39499750 |
| 122 | EEF2K | 0.39306011 |
| 123 | MAPKAPK3 | 0.39223112 |
| 124 | MAP3K9 | 0.39178411 |
| 125 | RAF1 | 0.39162291 |
| 126 | RPS6KB1 | 0.37298729 |
| 127 | IRAK1 | 0.37003134 |
| 128 | LYN | 0.36649337 |
| 129 | ATM | 0.36116082 |
| 130 | TTK | 0.36004293 |
| 131 | MAPK3 | 0.35579152 |
| 132 | CHUK | 0.34370019 |
| 133 | LATS1 | 0.33434616 |
| 134 | MAPK10 | 0.33110213 |
| 135 | TAOK3 | 0.32838623 |
| 136 | STK38 | 0.32611830 |
| 137 | STK3 | 0.32068074 |
| 138 | CDK4 | 0.31702191 |
| 139 | PRKCI | 0.29617768 |
| 140 | PAK4 | 0.29275943 |
| 141 | CDK8 | 0.28735614 |
| 142 | CDC7 | 0.28619715 |
| 143 | PRKAA2 | 0.26772884 |
| 144 | AURKA | 0.26771729 |
| 145 | MAPKAPK2 | 0.26730577 |
| 146 | GRK6 | 0.26295236 |
| 147 | CDK1 | 0.26291913 |
| 148 | JAK2 | 0.25677138 |
| 149 | SCYL2 | 0.25310432 |
| 150 | CSNK2A1 | 0.24363902 |
| 151 | SIK2 | 0.23689300 |
| 152 | GSK3B | 0.22404576 |
| 153 | AKT1 | 0.22115539 |
| 154 | AURKB | 0.20472016 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 4.19855046 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.15429011 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 4.02088418 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.95112972 |
| 5 | DNA replication_Homo sapiens_hsa03030 | 2.86489891 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.64386976 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.49391907 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.29480728 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.21870855 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 2.19774458 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.98762629 |
| 12 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.95948151 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92655101 |
| 14 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.77570419 |
| 15 | Adherens junction_Homo sapiens_hsa04520 | 1.74191183 |
| 16 | RNA transport_Homo sapiens_hsa03013 | 1.72807650 |
| 17 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.72214528 |
| 18 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.70470276 |
| 19 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.69603666 |
| 20 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.64362920 |
| 21 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.62274845 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60953445 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.59216139 |
| 24 | Lysine degradation_Homo sapiens_hsa00310 | 1.59009345 |
| 25 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.58652129 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.55870736 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49767649 |
| 28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.49118563 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47388779 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.46799757 |
| 31 | Cell cycle_Homo sapiens_hsa04110 | 1.45357167 |
| 32 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44230681 |
| 33 | Tuberculosis_Homo sapiens_hsa05152 | 1.43211938 |
| 34 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.42116833 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40982031 |
| 36 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.39400676 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.39195390 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.37795585 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35048307 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34240366 |
| 41 | Homologous recombination_Homo sapiens_hsa03440 | 1.33528600 |
| 42 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.32696071 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32410092 |
| 44 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.30802719 |
| 45 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29401055 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23313725 |
| 47 | Malaria_Homo sapiens_hsa05144 | 1.22481053 |
| 48 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.19293043 |
| 49 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18986771 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 1.17033813 |
| 51 | Measles_Homo sapiens_hsa05162 | 1.16255957 |
| 52 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14049408 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.13616553 |
| 54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.12578448 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12376158 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.11953764 |
| 57 | Galactose metabolism_Homo sapiens_hsa00052 | 1.11286893 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.09837857 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 1.09431989 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.09428203 |
| 61 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.08841468 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 1.08224094 |
| 63 | Colorectal cancer_Homo sapiens_hsa05210 | 1.06367224 |
| 64 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.05618576 |
| 65 | Prion diseases_Homo sapiens_hsa05020 | 1.05218782 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.04843944 |
| 67 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03749478 |
| 68 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.00840868 |
| 69 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.99674942 |
| 70 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99340557 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.99286085 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99207488 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.99083019 |
| 74 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98484770 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.95794722 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94691836 |
| 77 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94630216 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91967608 |
| 79 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.91034741 |
| 80 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90499063 |
| 81 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89397486 |
| 82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.88717686 |
| 83 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.87290872 |
| 84 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86844796 |
| 85 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83794219 |
| 86 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82687720 |
| 87 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82424357 |
| 88 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.81851190 |
| 89 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.78767991 |
| 90 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.77937247 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.77338750 |
| 92 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76774089 |
| 93 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.76021497 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.75689984 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75224097 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.73292082 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73140458 |
| 98 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.73097309 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.72441108 |
| 100 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71657741 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71324940 |
| 102 | Thyroid cancer_Homo sapiens_hsa05216 | 0.71233917 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.71232833 |
| 104 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.70502740 |
| 105 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.69868999 |
| 106 | Amoebiasis_Homo sapiens_hsa05146 | 0.69722140 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69186922 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67459899 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.67122574 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.65327877 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65071334 |
| 112 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64706520 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64530274 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64130242 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63521546 |
| 116 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63148397 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.62971715 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58658299 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58528644 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56582167 |
| 121 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56244426 |
| 122 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54979619 |
| 123 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.54387600 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.54195819 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53674304 |
| 126 | Glioma_Homo sapiens_hsa05214 | 0.53011990 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52962694 |
| 128 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52231613 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.51391969 |
| 130 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51308170 |
| 131 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.51113019 |
| 132 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50216734 |
| 133 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49573433 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.48887332 |
| 135 | HTLV-I infection_Homo sapiens_hsa05166 | 0.47832335 |
| 136 | Tight junction_Homo sapiens_hsa04530 | 0.47817385 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.47363436 |
| 138 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46804186 |
| 139 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46525823 |
| 140 | Gap junction_Homo sapiens_hsa04540 | 0.45005947 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.43185264 |
| 142 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43176192 |
| 143 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.42776763 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.42057390 |
| 145 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41999054 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41480446 |
| 147 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41158160 |
| 148 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40722956 |
| 149 | RNA degradation_Homo sapiens_hsa03018 | 0.39459057 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.38078890 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.37836020 |
| 152 | Insulin secretion_Homo sapiens_hsa04911 | 0.34938187 |
| 153 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33374197 |
| 154 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.31441296 |
| 155 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30400566 |
| 156 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.29199269 |
| 157 | Pathways in cancer_Homo sapiens_hsa05200 | 0.27517085 |

